ES2195370T3 - Procedimiento para la preparacion de 2`-fluoro-5-metil-beta-l-arabinofuranosiluridina. - Google Patents

Procedimiento para la preparacion de 2`-fluoro-5-metil-beta-l-arabinofuranosiluridina.

Info

Publication number
ES2195370T3
ES2195370T3 ES98939087T ES98939087T ES2195370T3 ES 2195370 T3 ES2195370 T3 ES 2195370T3 ES 98939087 T ES98939087 T ES 98939087T ES 98939087 T ES98939087 T ES 98939087T ES 2195370 T3 ES2195370 T3 ES 2195370T3
Authority
ES
Spain
Prior art keywords
fluoro
methyl
arabinofuranosiluridine
beta
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98939087T
Other languages
English (en)
Inventor
Chung K Chu
Yong S Choi
Jinfa Du
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc
Original Assignee
University of Georgia Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia Research Foundation Inc filed Critical University of Georgia Research Foundation Inc
Application granted granted Critical
Publication of ES2195370T3 publication Critical patent/ES2195370T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02—Monosaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a un procedimiento nuevo y mejorado que permite preparar 2''-fluoro-5-metil-{be}-L-arabinofuranosiluridina representada por la fórmula (1) que presenta una actividad antiviral, más específicamente una potente actividad antiviral contra el virus de la hepatitis B y el virus Epstein-Barr.
ES98939087T 1997-07-23 1998-07-23 Procedimiento para la preparacion de 2`-fluoro-5-metil-beta-l-arabinofuranosiluridina. Expired - Lifetime ES2195370T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5348897P 1997-07-23 1997-07-23

Publications (1)

Publication Number Publication Date
ES2195370T3 true ES2195370T3 (es) 2003-12-01

Family

ID=21984622

Family Applications (2)

Application Number Title Priority Date Filing Date
ES03075945T Expired - Lifetime ES2249678T3 (es) 1997-07-23 1998-07-23 Procedimiento de preparacion de l-ribosa.
ES98939087T Expired - Lifetime ES2195370T3 (es) 1997-07-23 1998-07-23 Procedimiento para la preparacion de 2`-fluoro-5-metil-beta-l-arabinofuranosiluridina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES03075945T Expired - Lifetime ES2249678T3 (es) 1997-07-23 1998-07-23 Procedimiento de preparacion de l-ribosa.

Country Status (21)

Country Link
US (2) US6512107B2 (es)
EP (2) EP1327637B1 (es)
KR (1) KR100247505B1 (es)
CN (1) CN1113892C (es)
AR (1) AR009092A1 (es)
AT (2) ATE304547T1 (es)
AU (1) AU8758298A (es)
BR (1) BR9810804B1 (es)
DE (2) DE69812959T2 (es)
DK (1) DK1327637T3 (es)
ES (2) ES2249678T3 (es)
ID (1) ID20624A (es)
IL (1) IL121730A (es)
IN (1) IN186807B (es)
MY (1) MY117314A (es)
PT (2) PT998482E (es)
SA (1) SA98180771B1 (es)
SI (1) SI1327637T1 (es)
TR (1) TR199701051A2 (es)
TW (1) TW434252B (es)
WO (2) WO1999005157A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW434252B (en) 1997-07-23 2001-05-16 Univ Georgia Res Found Process for the preparation of 2'-fluoro-5-methyl-β-L-arabino-furanosyluridine
KR100449618B1 (ko) * 1998-03-27 2004-11-16 부광약품 주식회사 2'-플루오로-5-메틸-β-L-아라비노푸라노실유리딘의 제조방법
US6462191B1 (en) * 2000-07-13 2002-10-08 Air Products And Chemicals, Inc. Synthesis of 2-deoxy-2-fluoro-arabinose derivatives
IL158185A0 (en) * 2001-03-30 2004-03-28 Triangle Pharmaceuticals Inc PROCESS FOR THE PREPARATION OF 2'-HALO-&beta -L-ARABINOFURANOSYL NUCLEOSIDES
KR100487992B1 (ko) * 2001-10-25 2005-05-09 부광약품 주식회사 2'-플루오로-5-메틸-β-엘-아라비노푸라노실유리딘의 황유도체
EP1569658A4 (en) * 2001-12-20 2007-05-30 Pharmassett Ltd TREATMENT OF EBV AND KHSV INFECTION AND AN ASSOCIATED ABNORMAL CELL PROLIFERATION
KR100976778B1 (ko) 2003-04-17 2010-08-18 부광약품 주식회사 1-（2'-플루오로-베타-엘-아라비노푸라노실）티민의 황 유도체를 유효 활성 성분으로 하는 b형 간염 바이러스 치료제
ES2725457T3 (es) 2004-09-14 2019-09-24 Gilead Pharmasset Llc Preparación de ribofuranosil pirimidinas y purinas 2'fluoro-2'-alquil-sustituidas u otras opcionalmente sustituidas y sus derivados
BRPI0613796A2 (pt) 2005-06-07 2011-02-15 Univ Yale composicões farmacêuticas e seus usos, e métodos de tratamento de cáncer e outras condições ou estados patológicos, por meio do uso de clevudina (lfmau) e telbivudina (ldt)
PT2514750E (pt) 2007-06-18 2014-01-23 Sunshine Lake Pharma Co Ltd Tiazolil dihidropirimidinas substituídas com bromo-fenilo
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
KR20200118827A (ko) 2018-02-02 2020-10-16 마베릭스 온콜로지, 잉크. 젬시타빈 모노포스페이트의 소분자 약물 컨쥬게이트
CN109320564B (zh) * 2018-10-26 2022-05-31 浙江晟格生物科技有限公司 一种l-来苏糖的制备工艺
CN109467541A (zh) * 2018-11-17 2019-03-15 扬州工业职业技术学院 一种绿色合成克拉夫定药物中间体的方法
CN109467583A (zh) * 2018-11-17 2019-03-15 扬州工业职业技术学院 一种克拉夫定的绿色合成工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714473A1 (de) * 1987-04-30 1988-11-10 Basf Ag Kontinuierliches verfahren zur epimerisierung von zuckern, insbesondere von d-arabinose zu d-ribose
EP0400064B1 (en) 1988-02-09 1993-04-21 Uop Solid catalysts for continuous interconversion of epimeric aldoses and aldose analogs
DE4002727A1 (de) * 1990-01-31 1991-08-01 Bayer Ag Mischungen aus waessrigen polymerdispersionen
US5587362A (en) 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
US5808040A (en) 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
TW434252B (en) 1997-07-23 2001-05-16 Univ Georgia Res Found Process for the preparation of 2'-fluoro-5-methyl-β-L-arabino-furanosyluridine

Also Published As

Publication number Publication date
TR199701051A3 (tr) 1999-03-22
US6512107B2 (en) 2003-01-28
WO1999005158A1 (en) 1999-02-04
SA98180771B1 (ar) 2006-10-29
CN1113892C (zh) 2003-07-09
DE69812959D1 (de) 2003-05-08
DE69831619T2 (de) 2006-06-14
BR9810804B1 (pt) 2012-01-10
EP0998482B1 (en) 2003-04-02
KR100247505B1 (ko) 2000-03-15
DE69831619D1 (de) 2005-10-20
IL121730A0 (en) 1998-02-22
TR199701051A2 (xx) 1999-03-22
EP0998482A1 (en) 2000-05-10
KR19990013297A (ko) 1999-02-25
DE69812959T2 (de) 2004-03-04
ES2249678T3 (es) 2006-04-01
TW434252B (en) 2001-05-16
ID20624A (id) 1999-01-28
PT1327637E (pt) 2005-11-30
BR9810804A (pt) 2000-09-12
EP1327637B1 (en) 2005-09-14
DK1327637T3 (da) 2006-01-16
SI1327637T1 (sl) 2005-12-31
AR009092A1 (es) 2000-03-08
US20020062018A1 (en) 2002-05-23
US6894159B2 (en) 2005-05-17
PT998482E (pt) 2003-08-29
AU8758298A (en) 1999-02-16
CN1206012A (zh) 1999-01-27
ATE304547T1 (de) 2005-09-15
IL121730A (en) 2005-03-20
MY117314A (en) 2004-06-30
IN186807B (es) 2001-11-10
US20030139593A1 (en) 2003-07-24
WO1999005157A1 (en) 1999-02-04
ATE236187T1 (de) 2003-04-15
EP1327637A1 (en) 2003-07-16

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
YU31000A (sh) Sferoidi, postupak za dobijanje i farmaceutske kompozicije
BR9812837A (pt) Processo para fazer um composto, e, composto
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
LT2003017A (en) Polymorphs of an epothilone analog
CR6540A (es) Trifluorobutenos nematicidas
WO2004096818A3 (en) Method and compositions for identifying anti-hiv therapeutic compounds
GB0011203D0 (en) Chemical compounds
UY27552A1 (es) 17a- alquil- 17b- oxi-estratrienos y productos intermediarios para su preparacinn, uso de los 17a-alquil-17b-oxi-estratrienos para obtener medicamentos y preparados farmacéuticos.
IL160045A0 (en) Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
BRPI9917739B8 (pt) composto intermediário na preparação de inibidores de cox-2
MX9203644A (es) Derivados substituidos de la 3-aril-pirrolidin-2,4-diona y procedimiento para su obtencion.
ES2187261A1 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
ES2108969T3 (es) Utilizacion de analogos de didesoxinucleosidos en el tratamiento de infecciones virales.
AR009092A1 (es) Un procedimiento para preparar 2'-fluoro-5-metil-beta-l- arabinofuranosiluridina.
BR0111729A (pt) 1-aril-4-oxo-1,4-dihidro-3-quinolinacarboxamidas como agentes antivirais
MY117789A (en) Pyrroloquinolones as antiviral agents
BR9808923A (pt) Composto, e, processo para fazer o mesmo
SE9904128D0 (sv) Novel compounds
BR9807785A (pt) Processo para a preparação do composto, e, composto
UY26250A1 (es) Sulfonamidas sustituidas con naftilo
BR0011559A (pt) Processo para a preparação de derivados de 10, 11-metano benzossuberano
DK0685235T3 (da) Ekstrakter af Piliostigma thonningii, anvendelse heraf og formuleringer, som indeholder dem